Cargando…
Targeting K-Ras-mediated DNA damage response in radiation oncology: Current status, challenges and future perspectives
Approximately 60% of cancer patients receive curative or palliative radiation. Despite the significant role of radiotherapy (RT) as a curative approach for many solid tumors, tumor recurrence occurs, partially because of intrinsic radioresistance. Accumulating evidence indicates that the success of...
Autor principal: | Toulany, Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596599/ https://www.ncbi.nlm.nih.gov/pubmed/36313934 http://dx.doi.org/10.1016/j.ctro.2022.10.004 |
Ejemplares similares
-
Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation
por: Toulany, Mahmoud, et al.
Publicado: (2011) -
Genitourinary Oncology: Current Status and Future Challenges
por: Bukowski, Ronald M.
Publicado: (2011) -
Current status and future developments in predicting outcomes in radiation oncology
por: Niraula, Dipesh, et al.
Publicado: (2022) -
Dual targeting of PI3K and MEK enhances the radiation response of K-RAS mutated non-small cell lung cancer
por: Toulany, Mahmoud, et al.
Publicado: (2016) -
Radiation Oncology Research in Asia: Current Status and a Peep Into the Future From the Federation of Asian Organizations for Radiation Oncology
por: Chopra, Supriya, et al.
Publicado: (2023)